SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+31.2%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$1.14B
AUM Growth
+$1.14B
(+26%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-15.61%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
104
New
30
Increased
28
Reduced
25
Closed
13
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$43.7M |
| 2 |
TG Therapeutics
TGTX
|
$38.3M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$23.2M |
| 4 |
Keros Therapeutics
KROS
|
$18.1M |
| 5 |
Biogen
BIIB
|
$15.7M |
Top Sells
| 1 |
Jasper Therapeutics
JSPR
|
$255M |
| 2 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$46.4M |
| 3 |
GSK
GSK
|
$41.1M |
| 4 |
Viking Therapeutics
VKTX
|
$30.3M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$29.3M |
Sector Composition
| 1 | Healthcare | 99.93% |
| 2 | Consumer Staples | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$13.8B
| $59.7M | 4.43% | 259,749 +10,300 | +4% | +$2.37M |
|
|
EDAP
2
EDAP TMS
EDAP
$84.5M
| $53.1M | 3.94% | 7,227,353 +1,012 | +0% | +$7.44K |
|
|
3
Iovance Biotherapeutics
IOVA
$807M
| $51.9M | 3.86% | 3,505,000 +2,950,000 | +532% | +$43.7M |
|
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $49.2M | 3.65% | 3,486,440 -2,078,000 | -37% | -$29.3M |
|
|
5
TG Therapeutics
TGTX
$4.65B
| $48.2M | 3.58% | 3,168,456 +2,518,456 | +387% | +$38.3M |
|
6
Celcuity
CELC
$2.17B
| $37.4M | 2.78% | 1,731,338 -448,143 | -21% | -$9.68M |
|
|
7
Jasper Therapeutics
JSPR
$45.5M
| $34.9M | 2.59% | 1,187,096 -8,683,884 | -88% | -$255M |
|
8
Neuropace
NPCE
$303M
| $32.1M | 2.38% | 2,433,168 | – | – |
|
9
ESSA Pharma
EPIX
$11.4M
| $30.5M | 2.26% | 3,589,558 -738,064 | -17% | -$6.27M |
|
10
Organogenesis Holdings
ORGO
$653M
| $27.2M | 2.02% | 9,573,198 +610,198 | +7% | +$1.73M |
|
11
Axogen
AXGN
$743M
| $25.1M | 1.86% | 3,105,815 +510,000 | +20% | +$4.12M |
|
12
Humana
HUM
$36.5B
| $25M | 1.85% | 72,006 -1,700 | -2% | -$589K |
|
13
Surmodics
SRDX
$487M
| $23.5M | 1.74% | 800,820 +29,120 | +4% | +$854K |
|
14
Revolution Medicines
RVMD
$7.1B
| $23.5M | 1.74% | 728,700 +476,700 | +189% | +$15.4M |
|
15
IDEAYA Biosciences
IDYA
$2.15B
| $23.4M | 1.74% | 533,515 -31,185 | -6% | -$1.37M |
|
|
ONC
16
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $23.2M | 1.72% | +148,100 | New | +$23.2M |
|
17
C4 Therapeutics
CCCC
$185M
| $20.1M | 1.49% | 2,458,996 +623,000 | +34% | +$5.09M |
|
18
Penumbra
PEN
$10.6B
| $19.1M | 1.42% | 85,700 +6,300 | +8% | +$1.41M |
|
19
Verastem
VSTM
$569M
| $18.2M | 1.35% | 1,540,634 +115,000 | +8% | +$1.36M |
|
|
20
Keros Therapeutics
KROS
$618M
| $18.1M | 1.34% | +273,600 | New | +$18.1M |
|
21
Treace Medical Concepts
TMCI
$464M
| $17.6M | 1.3% | 1,345,648 +331,643 | +33% | +$4.33M |
|
22
HCA Healthcare
HCA
$94.5B
| $17.2M | 1.27% | 51,441 -50,059 | -49% | -$16.7M |
|
23
Nurix Therapeutics
NRIX
$714M
| $16.4M | 1.22% | 1,115,000 +972,000 | +680% | +$14.3M |
|
24
Castle Biosciences
CSTL
$696M
| $16.1M | 1.19% | 725,457 +699,457 | +2,690% | +$15.5M |
|
25
iRadimed
IRMD
$921M
| $15.9M | 1.18% | 361,630 -281,576 | -44% | -$12.4M |
|